Increasing Cholesterol Medication Adherence With Financial Incentives May Be Cost Effective

Increasing cholesterol medication adherence with financial incentives may be cost-effective

Boston, MA – A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients ...

Cholesterol-Slashing Drugs Market Is Likely to Register Double Digit CAGR During 2017 to 2025

This is anticipated to fuel the growth of the cholesterol-slashing drugs market during the forecast period. Moreover, high prevalence rate and increase in geriatric population boost the growth of the ...

Study: Drug combo could reduce heart attack risk

20 (UPI) --A combination of in-development drugs that lower triglycerides levels and approved statins that reduce cholesterol levels may reduce ... only one of either of these DNA variants. Statins in...

Viking Almost Triples After Fatty Liver Drug Meets Study Goals

Viking’s medicine, VK2809, cut the bad cholesterol or low-density lipoprotein ... NASH, spurred on by ever increasing rates of obesity, is expected to be a multi-billion dollar market, and drug compan...

Computer model reveals effect of increased cholesterol on specific ion channel in heart

Using a computer model, researchers from North Carolina State University and the University of Illinois at Chicago have revealed the effect of increased amounts of cholesterol on a specific ion channe...